MEDIFAST INC Ownership

MED Stock  USD 22.83  0.07  0.31%   
MEDIFAST INC holds a total of 10.94 Million outstanding shares. The majority of MEDIFAST INC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MEDIFAST INC to benefit from reduced commissions. Thereupon, institutional holders are subject to a different set of regulations than regular investors in MEDIFAST INC. Please pay attention to any change in the institutional holdings of MEDIFAST INC as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
 
Shares in Circulation  
First Issued
1996-09-30
Previous Quarter
10.9 M
Current Value
11 M
Avarage Shares Outstanding
11.1 M
Quarterly Volatility
3.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as MEDIFAST INC in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of MEDIFAST INC, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
At present, MEDIFAST INC's Dividend Yield is projected to increase slightly based on the last few years of reporting. The current year's Dividend Payout Ratio is expected to grow to 0.77, whereas Dividend Paid And Capex Coverage Ratio is forecasted to decline to 2.11. The current year's Common Stock Shares Outstanding is expected to grow to about 12.2 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 173.4 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

MEDIFAST Stock Ownership Analysis

About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity recorded earning per share (EPS) of 6.19. The firm last dividend was issued on the 18th of September 2023. MEDIFAST INC had 1:20 split on the February 14, 2011. Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people. To find out more about MEDIFAST INC contact Michael MacDonald at 410 581 8042 or learn more at https://medifastinc.com.
Besides selling stocks to institutional investors, MEDIFAST INC also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different MEDIFAST INC's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align MEDIFAST INC's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

MEDIFAST INC Quarterly Liabilities And Stockholders Equity

302.76 Million

MEDIFAST INC Insider Trades History

Roughly 3.0% of MEDIFAST INC are currently held by insiders. Unlike MEDIFAST INC's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against MEDIFAST INC's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of MEDIFAST INC's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

MEDIFAST Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Charles Schwab Investment Management Inc2023-12-31
186.2 K
Hotchkis & Wiley Capital Management Llc2023-12-31
167.3 K
American Century Companies Inc2023-12-31
139.9 K
Northern Trust Corp2023-12-31
125.5 K
Aqr Capital Management Llc2023-12-31
110.4 K
Ubs Group Ag2023-12-31
92 K
Ameriprise Financial Inc2023-12-31
91.3 K
Amvescap Plc.2023-12-31
87.9 K
Prudential Financial Inc2023-12-31
84 K
Blackrock Inc2023-12-31
1.8 M
Vanguard Group Inc2023-12-31
1.7 M
Note, although MEDIFAST INC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MEDIFAST INC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDIFAST INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDIFAST INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDIFAST INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

MEDIFAST INC Corporate Filings

8th of May 2024
Other Reports
ViewVerify
8K
29th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
26th of April 2024
Other Reports
ViewVerify
F4
19th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Dividend Share
3.3
Earnings Share
6.19
Revenue Per Share
82.404
Quarterly Revenue Growth
(0.50)
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.